The Dime

Most cannabis automation fails for a simple reason.
It optimizes motion instead of understanding.
Automation executes. Robotics adapts.
That distinction matters in an industry where variability is unavoidable and capital is limited.
This episode breaks down why feedback loops matter more than machines, why fully automated facilities are still far off, and how teams should think about constraints before investing.
This week, we sit down with Nohtal Partansky to cover:
Why automation breaks under variability
Automation vs robotics, clearly defined
How to avoid expensive missteps
 
Chapters
00:00 Understanding Automation in Cannabis Manufacturing
03:02 The Role of Robotics vs. Automation
05:45 Consultative Approach to Automation
08:54 Challenges in Cultivation Automation
11:59 Designing for Variability in Automation
15:01 Iterative Development and Customer Feedback
18:08 Identifying Design vs. Customer Issues
21:06 Adapting to Environmental Nuances
23:55 Conveying Value in Automation Solutions
27:09 Strategic Approaches to Automation in Supply Chain
30:10 Optimizing Pre-Roll Production Processes
33:44 Understanding Tolerance Levels in Manufacturing
36:39 Intellectual Property in the Cannabis Industry
42:26 Innovations in Cannabis Manufacturing
45:32 Challenges in Automation and Scaling
50:51 Improving Processes and Training in Cannabis Operations
Summary
In this conversation, Bryan Fields and Nohtal Partansky delve into the intricacies of automation and robotics within the cannabis manufacturing industry. They discuss the differences between fully automated and automated processes, the consultative approach to implementing automation, and the challenges faced in cultivation. The conversation highlights the importance of feedback loops in robotics, the iterative design process, and the need for a deep understanding of customer needs. They also touch on the significance of protecting intellectual property while fostering innovation in a rapidly evolving industry.
Guest Links
https://www.instagram.com/sortingroboticsinc/
https://www.youtube.com/@sortingrobotics
https://www.linkedin.com/company/sortingrobotics/
https://www.sortingrobotics.com/
https://www.linkedin.com/in/nohtal/
Our Links
Bryan Fields on Twitter
Kellan Finney on Twitter
The Dime on Twitter
Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.
At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.
The Dime is a top 5% most shared  global podcast
The Dime is a top 10 Cannabis Podcast 
The Dime has a New Website. Shhhh its not finished.
🎥 YouTube:  The Dime
📸 Instagram:  The Dime
https://www.newton-insights.com/

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Jaunty’s rise to the top of the New York cannabis market was not an overnight success.
It was built through discipline in a market uniquely designed
New York’s rollout remains unforgiving.
One store openings, supply and demand constraints, and continuous price compression forced every decision into the open.
This week we sit down with Nicolas Guarino, Co-Founder and CEO of Jaunty, to break down what it actually takes to survive and scale in one of the most interesting cannabis markets in the country.
This week we sit down with Nick to discuss:
Why consistency becomes the only real moat as prices fall
How New York’s rollout punished assumptions and rewarded preparedness
Capital discipline, supplier trust, and avoiding overspend death spirals
Chapters
00:00 Introduction to Jaunty and Nicolas Guarino
03:06 The Journey into the Cannabis Industry
06:07 Challenges and Lessons Learned in CBD
09:00 Transitioning to Recreational Cannabis
11:54 Building a Brand in a Competitive Market
15:07 Navigating Market Dynamics and Growth Challenges
18:07 The Importance of Support and Resilience
20:49 Understanding Market Economics and Consumer Behavior
23:55 Future Prospects for Cannabis in New York
31:48 The Economics of Cannabis Production
36:29 The Importance of Consistency in Branding
41:11 Navigating Challenges in Cannabis Operations
46:10 Strategic Planning for Future Growth
51:56 Inventory Management and Cost Control
56:02 Preparing for Market Consolidation
58:11 Final Thoughts and Future Directions
 
About: Nicolas Guarino is Co-Founder and CEO of Jaunty. As a GMP-certified 100% New York company working in cannabis extraction since 2017, Jaunty has been producing and distributing the finest solventless hash, live resin, and distillate cannabis products in its mission to close the gap between flower and oil. With state-of-the-art manufacturing facilities in Hoosick Falls, NY, Jaunty is one of New York's leading companies licensed for all adult-use cannabis supply chain activities outside of retail, including cultivation, processing, manufacturing, and distribution. They produce and distribute one of New York’s best-selling cannabis vape brands, available in all of the state’s licensed dispensaries, and their product portfolio also features gummies, concentrates, and disposable vapes.
Summary
In this episode, Bryan Fields interviews Nicolas Guarino, co-founder and CEO of Jaunty, discussing his journey in the cannabis industry, the challenges faced in the CBD market, and the transition to recreational cannabis. They explore the importance of brand consistency, financial strategies for growth, and the dynamics of the New York cannabis market. Nicholas shares insights on consumer education, market predictions, and the future vision for Jaunty emphasizing the need for adaptability and resilience in a fast-paced industry.
Guest Links
https://jaunty.com/
https://x.com/getjaunty
https://www.linkedin.com/company/get-jaunty
https://www.instagram.com/get_jaunty/
https://www.linkedin.com/in/nicolas-guarino-43939b103/
Our Links:
Bryan Fields on Twitter
Kellan Finney on Twitter
The Dime on Twitter
Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.
At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.
The Dime is a top 5% most shared  global podcast
The Dime is a top 10 Cannabis Podcast 
The Dime has a New Website. Shhhh its not finished.
🎥 YouTube:  The Dime
📸 Instagram:  The Dime
https://www.newton-insights.com/

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Before CBD was discussed by a President in the Oval Office, it was a medical necessity.
The Charlotte Figi story is well documented — and powerful.
Not because it was emotional, but because it forced a serious medical conversation.
Stories like Charlotte’s change how physicians, regulators, and institutions think about where cannabinoid therapy belongs — not as a last resort, but as a legitimate option.
Charlotte’s Web was built around that reality. By recognizing that cannabis does have medicinal properties — and that patients should have access to a plant-based option when it can materially improve quality of life — the company focused on trust, standards, and medical credibility first.
This week, we sit down with Bill Morachnick to break down:
Why CBD earned acceptance through medical trust, not consumer marketing
How physician comfort, reimbursement pathways, and standards changed the conversation
CBD in the Oval Office — and what that signals for the future of cannabis
 
Chapters
00:00 Introduction to Charlotte's Web and Bill Morachnick
03:00 The Inspiring Story of Charlotte Figi
05:51 The Executive Order and Its Implications
08:59 The Role of Education in CBD Acceptance
12:12 Challenges and Misconceptions in the Cannabis Industry
15:03 The Future of CBD and Medical Recommendations
18:06 The Impact of Federal Reimbursement on CBD
21:08 Defloria and the Future of Cannabis Research
24:01 Navigating Regulatory Changes and Industry Challenges
27:03 The Importance of Quality and Consistency in CBD Products
30:02 The Potential for Pharmaceutical Collaborations
33:04 Looking Ahead: The Future of CBD and Cannabis
36:13 Final Thoughts and Audience Engagement
Summary
In this episode, Bryan Fields interviews Bill Morachnick, CEO of Charlotte's Web, discussing the company's inspiring origins, the recent executive order regarding CBD, and the future of cannabis as a medicinal product. Bill shares the powerful story of Charlotte Figi, whose life was transformed by CBD, and emphasizes the importance of education in changing perceptions about cannabis. The conversation also touches on the challenges faced by the industry, the potential for pharmaceutical collaborations, and the impact of federal reimbursement on CBD products.
Guest Links:
https://www.trycharlottesweb.com/
https://www.charlottesweb.com/
https://www.youtube.com/charlotteswebcbd
https://www.instagram.com/charlotteswebcbd/
https://www.linkedin.com/in/bill-morachnick-01318a6/
https://www.linkedin.com/company/charlottesweb/
Our Links:
Bryan Fields on Twitter
Kellan Finney on Twitter
The Dime on Twitter
Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.
At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.
The Dime is a top 5% most shared  global podcast
The Dime is a top 10 Cannabis Podcast 
The Dime has a New Website. Shhhh its not finished.
🎥 YouTube:  The Dime
📸 Instagram:  The Dime
https://www.newton-insights.com/
 

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Everyone wants their product and brand to be known for consistency .
Almost no one is willing to do the difficult work that makes consistency possible.
This week we sit down with Ryan Crandall, Chief Commercial Officer at MariMed, to break down:
Why most cannabis brands fail at scale — and how process control, not an artisanal mindset, determines who lasts
How MariMed engineers consistency across states by centralizing inputs & testing aggressively,
What it actually takes to make effects-based products consistent and repeatable
 
Chapters
00:00 Introduction to the Cannabis Industry and Edibles
03:05 The Evolution of Edibles: From Early Days to Now
06:01 Ensuring Consistency Across State Lines
09:09 Quality Control and Testing in Edibles
12:01 Consumer Education and Brand Trust
15:13 MariMed Brand Portfolio and Market Strategy
18:06 Role of R&D in Product Development
21:00 Future Trends and Innovations in Edibles
24:03 Building Relationships with Budtenders and Consumers
27:58 Exploring Cannabinoids: THCV and CBG Effects
30:06 Understanding Edible Experiences and Consumer Expectations
32:00 Responsible Product Development in the Cannabis Industry
33:52 Brand Strategy and Market Penetration in New States
35:51 Innovative Products: Vibations and Consumer Convenience
38:04 Navigating the Hemp Market and Brand Expansion
39:52 Consumer Behavior: Beverages vs. Edibles in Cannabis
44:02 The Importance of Team and Company Culture
Guest Links:
https://www.marimedinc.com/
https://www.linkedin.com/company/marimed-inc/about/
https://www.linkedin.com/in/ryan-crandall-43133b12/
https://x.com/MariMed_Inc
Summary
In this episode, Bryan Fields interviews Ryan Crandall, Chief Commercial Officer at MariMed, discussing the evolution of the cannabis industry, particularly focusing on edibles. They explore the importance of consistency in product quality across different states, the role of research and development in product innovation, and the significance of branding and consumer trust. Ryan shares insights into MariMeds diverse product portfolio and their approach to quality control and testing procedures. The conversation also touches on the future of hemp and cannabinoids, as well as the beverage market's impact on consumer behavior.
Our Links:
Bryan Fields on Twitter
Kellan Finney on Twitter
The Dime on Twitter
Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.
At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.
The Dime is a top 5% most shared  global podcast
The Dime is a top 10 Cannabis Podcast 
The Dime has a New Website. Shhhh its not finished.
🎥 YouTube:  The Dime
📸 Instagram:  The Dime
https://www.newton-insights.com/

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Schedule III isn’t the finish line.
It’s the starting gun.
The EO said a lot — but most operators aren’t ready for what it actually means.
This week we sit down with Zach Edge and Dr. Matthew Moore to break down:
Why Schedule III is guidance, not rules — and why the real impact comes during rulemaking
What GMP, CFR, and pharmaceutical-grade manufacturing will actually require from operators
Which parts of the supply chain face the biggest disruption as cannabis moves forward
Chapters
00:00 Historic Changes in Cannabis Scheduling
03:13 The Impact of Hemp in the New Landscape
06:07 Strategic Shifts for Cannabis Operators
08:59 Navigating Regulatory Changes
11:58 The Role of Pharmacies in the New Market
15:04 Global Trade and Competition in Cannabis
17:53 Research Opportunities and Challenges
21:02 Veterans and the Future of CBD
24:02 The Supply Chain Dynamics
26:47 The Future of Hemp and CBD Products
29:56 Final Thoughts on the Cannabis Industry
 
Summary:
In this episode, Bryan Fields discusses the recent changes in cannabis scheduling with experts Zach Edge and Matthew Moore. They explore the implications of the new executive order, particularly regarding hemp and its potential impact on the industry. The conversation delves into the strategic shifts that cannabis operators need to consider, the role of compounding pharmacies, and the opportunities for research that arise from the new regulations. They also discuss the challenges in the supply chain and the potential market dynamics as the industry evolves.
 
Guest Links:
https://www.linkedin.com/company/the-rho-advisory/
https://www.linkedin.com/in/zach-edge/
https://www.linkedin.com/in/mmoore09/
Our Links:
Bryan Fields on Twitter
Kellan Finney on Twitter
The Dime on Twitter
Extraction Teams: Want to cut costs and get more out of every run? Unlock hidden revenue by extracting more from the same input—with Newton Insights.
At Eighth Revolution (8th Rev), we provide services from capital to cannabinoid and everything in between in the cannabinoid industry.
The Dime is a top 5% most shared  global podcast
The Dime is a top 10 Cannabis Podcast 
The Dime has a New Website. Shhhh its not finished.
🎥 YouTube:  The Dime
📸 Instagram:  The Dime
https://www.newton-insights.com/
 

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.